193 related articles for article (PubMed ID: 30460625)
1. Preclinical SPECT Imaging of Choroidal Neovascularization in Mice Using Integrin-Binding [
Ahn SJ; Lee HY; Hong HK; Jung JH; Park JH; Park KH; Kim SE; Woo SJ; Lee BC
Mol Imaging Biol; 2019 Aug; 21(4):644-653. PubMed ID: 30460625
[TBL] [Abstract][Full Text] [Related]
2. Imaging of Integrin α
Song YS; Park HS; Lee BC; Jung JH; Lee HY; Kim SE
Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416
[TBL] [Abstract][Full Text] [Related]
3. SPECT/CT Imaging of High-Risk Atherosclerotic Plaques using Integrin-Binding RGD Dimer Peptides.
Yoo JS; Lee J; Jung JH; Moon BS; Kim S; Lee BC; Kim SE
Sci Rep; 2015 Jun; 5():11752. PubMed ID: 26123253
[TBL] [Abstract][Full Text] [Related]
4. Identification of Angiogenesis Rich-Viable Myocardium using RGD Dimer based SPECT after Myocardial Infarction.
Lee MS; Park HS; Lee BC; Jung JH; Yoo JS; Kim SE
Sci Rep; 2016 Jun; 6():27520. PubMed ID: 27283041
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution and Internal Radiation Dosimetry of
Song YS; Kim JH; Lee BC; Jung JH; Park HS; Kim SE
Cancer Biother Radiopharm; 2018 Nov; 33(9):396-402. PubMed ID: 30133309
[TBL] [Abstract][Full Text] [Related]
6. Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature.
Liu Z; Jia B; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
Bioconjug Chem; 2010 Mar; 21(3):548-55. PubMed ID: 20184307
[TBL] [Abstract][Full Text] [Related]
7. Coordination-Mediated Synthesis of Purification-Free Bivalent
Taira Y; Uehara T; Tsuchiya M; Takemori H; Mizuno Y; Takahashi S; Suzuki H; Hanaoka H; Akizawa H; Arano Y
Bioconjug Chem; 2018 Feb; 29(2):459-466. PubMed ID: 29320158
[TBL] [Abstract][Full Text] [Related]
8. Integrin α(v)β₃-targeted radiotracer (99m)Tc-3P-RGD₂ useful for noninvasive monitoring of breast tumor response to antiangiogenic linifanib therapy but not anti-integrin α(v)β₃ RGD₂ therapy.
Ji S; Zheng Y; Shao G; Zhou Y; Liu S
Theranostics; 2013; 3(11):816-30. PubMed ID: 24312152
[TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD.
Sancey L; Ardisson V; Riou LM; Ahmadi M; Marti-Batlle D; Boturyn D; Dumy P; Fagret D; Ghezzi C; Vuillez JP
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2037-47. PubMed ID: 17674000
[TBL] [Abstract][Full Text] [Related]
10. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
11. Monitoring glioma growth and tumor necrosis with the U-SPECT-II/CT scanner by targeting integrin αvβ3.
Shao G; Zhou Y; Wang F; Liu S
Mol Imaging; 2013; 12(1):39-48. PubMed ID: 23348790
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.
Liu S; Hsieh WY; Jiang Y; Kim YS; Sreerama SG; Chen X; Jia B; Wang F
Bioconjug Chem; 2007; 18(2):438-46. PubMed ID: 17341108
[TBL] [Abstract][Full Text] [Related]
13. Manipulating Pharmacokinetics of Purification-Free
Uehara T; Sensui A; Ishioka S; Mizuno Y; Takahashi S; Takemori H; Suzuki H; Arano Y
Mol Pharm; 2020 May; 17(5):1621-1628. PubMed ID: 32275437
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.
Zhang X; Chen X
Appl Radiat Isot; 2007 Jan; 65(1):70-8. PubMed ID: 17011200
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of
Zheng J; Miao W; Huang C; Lin H
Ann Nucl Med; 2017 Jul; 31(6):486-494. PubMed ID: 28474165
[TBL] [Abstract][Full Text] [Related]
16. Ligands for mapping alphavbeta3-integrin expression in vivo.
Schottelius M; Laufer B; Kessler H; Wester HJ
Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
[TBL] [Abstract][Full Text] [Related]
17.
Siitonen R; Peuhu E; Autio A; Liljenbäck H; Mattila E; Metsälä O; Käkelä M; Saanijoki T; Dijkgraaf I; Jalkanen S; Ivaska J; Roivainen A
J Nucl Med; 2019 Oct; 60(10):1380-1387. PubMed ID: 30850498
[TBL] [Abstract][Full Text] [Related]
18. FITC-Labeled RGD Peptides as Novel Contrast Agents for Functional Fluorescent Angiographic Detection of Retinal and Choroidal Neovascularization.
Choi SW; Hong HK; Jeon J; Choi JY; Kim M; Kim P; Lee BC; Woo SJ
Cells; 2023 Jul; 12(14):. PubMed ID: 37508566
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin alphavbeta3 expression.
Jia B; Shi J; Yang Z; Xu B; Liu Z; Zhao H; Liu S; Wang F
Bioconjug Chem; 2006; 17(4):1069-76. PubMed ID: 16848417
[TBL] [Abstract][Full Text] [Related]
20. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression.
Morales-Avila E; Ferro-Flores G; Ocampo-García BE; De León-Rodríguez LM; Santos-Cuevas CL; García-Becerra R; Medina LA; Gómez-Oliván L
Bioconjug Chem; 2011 May; 22(5):913-22. PubMed ID: 21513349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
